1. Home
  2. SERA vs DALN Comparison

SERA vs DALN Comparison

Compare SERA & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • DALN
  • Stock Information
  • Founded
  • SERA 2008
  • DALN 1954
  • Country
  • SERA United States
  • DALN United States
  • Employees
  • SERA N/A
  • DALN 451
  • Industry
  • SERA Precision Instruments
  • DALN Newspapers/Magazines
  • Sector
  • SERA Health Care
  • DALN Consumer Discretionary
  • Exchange
  • SERA Nasdaq
  • DALN Nasdaq
  • Market Cap
  • SERA 85.6M
  • DALN 79.8M
  • IPO Year
  • SERA 2021
  • DALN 2008
  • Fundamental
  • Price
  • SERA $2.38
  • DALN $14.97
  • Analyst Decision
  • SERA
  • DALN
  • Analyst Count
  • SERA 0
  • DALN 0
  • Target Price
  • SERA N/A
  • DALN N/A
  • AVG Volume (30 Days)
  • SERA 102.6K
  • DALN 89.3K
  • Earning Date
  • SERA 08-06-2025
  • DALN 07-30-2025
  • Dividend Yield
  • SERA N/A
  • DALN N/A
  • EPS Growth
  • SERA N/A
  • DALN N/A
  • EPS
  • SERA N/A
  • DALN N/A
  • Revenue
  • SERA $108,000.00
  • DALN $121,119,000.00
  • Revenue This Year
  • SERA $390.13
  • DALN N/A
  • Revenue Next Year
  • SERA $440.54
  • DALN N/A
  • P/E Ratio
  • SERA N/A
  • DALN N/A
  • Revenue Growth
  • SERA 0.94
  • DALN N/A
  • 52 Week Low
  • SERA $1.37
  • DALN $3.66
  • 52 Week High
  • SERA $9.13
  • DALN $16.10
  • Technical
  • Relative Strength Index (RSI)
  • SERA 46.00
  • DALN 75.05
  • Support Level
  • SERA $2.17
  • DALN $14.83
  • Resistance Level
  • SERA $2.50
  • DALN $15.00
  • Average True Range (ATR)
  • SERA 0.19
  • DALN 0.19
  • MACD
  • SERA -0.02
  • DALN -0.32
  • Stochastic Oscillator
  • SERA 33.66
  • DALN 39.29

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.

Share on Social Networks: